Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV Proceeding/Conference:Journal of Hepatology | 2006 |